Cargando…
Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study
BACKGROUND: Regorafenib is a multi-kinase inhibitor, which was shown to be effective for patients with metastatic colorectal cancer refractory to standard therapies. However, its patterns of response has not yet been fully understood. METHODS: Clinical records of 10 patients who received regorafenib...
Autores principales: | Ozaki, Yukinori, Shindoh, Junichi, Gonoi, Wataru, Nishioka, Yujiro, Kondoh, Chihiro, Tanabe, Yuko, Matoba, Shuichiro, Kuroyanagi, Hiroya, Hashimoto, Masaji, Takano, Toshimi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800281/ https://www.ncbi.nlm.nih.gov/pubmed/29402244 http://dx.doi.org/10.1186/s12885-018-4067-5 |
Ejemplares similares
-
Curative resection for locally advanced sigmoid colon cancer using neoadjuvant chemotherapy with FOLFOX plus panitumumab: A case report
por: Tomizawa, Kenji, et al.
Publicado: (2017) -
Prognostic value of programmed death‐ligand 1 expression in patients with stage III colorectal cancer
por: Koganemaru, Shigehiro, et al.
Publicado: (2017) -
Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study
por: Ozaki, Yukinori, et al.
Publicado: (2018) -
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report
por: Ozaki, Yukinori, et al.
Publicado: (2017) -
Effectiveness of self-help workbook intervention on quality of life in cancer patients receiving chemotherapy: results of a randomized controlled trial
por: Takano, Toshimi, et al.
Publicado: (2021)